GATX vs RTX
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
GATX exhibits strong fundamental health with a Piotroski F-Score of 7/9, indicating robust operational efficiency and financial stability. While the stock trades at a premium to its defensive Graham Number ($126.27), it remains significantly undervalued relative to its growth-based intrinsic value of $269.04, supported by an exceptional PEG ratio of 0.64. Strong double-digit earnings growth (25.8% YoY) and high operating margins (30.96%) outweigh the bearish insider sentiment and current technical weakness. The company's liquidity position is exceptional, as evidenced by a current ratio of 11.03, mitigating the risks associated with its high debt-to-equity ratio.
RTX exhibits stable financial health with a Piotroski F-Score of 5/9, yet it is trading at a severe premium compared to its Graham Number ($73.73) and Intrinsic Value ($96.67). While the company boasts an exceptional track record of earnings beats over 25 quarters and solid revenue growth, the valuation is stretched with a PEG ratio of 2.75. This fundamental overvaluation is compounded by bearish insider sentiment and a weak technical trend, suggesting that while the business is strong, the stock price is currently decoupled from its deterministic value.
Compare Another Pair
Related Comparisons
GATX vs RTX: Head-to-Head Comparison
This page compares GATX Corporation (GATX) and RTX Corporation (RTX) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.